Converge Bio

Backed by

Visit Website

View Jobs

Raised $25M Series A on January 13, 2026

Converge Bio is redefining the intersection of biology and artificial intelligence. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs, faster leveraging the power of Generative AI and Large Language Models (LLMs) trained on biological languages.

Tel Aviv, Israel

·

$25M Series A

·

Biotech

·

Remote

·

11–50

Explore similar companies to Converge Bio

Enveda

Advancing nature-inspired drugs.

Biotech · Series E · Remote · Based in Boulder

Kingdom Supercultures

Natural functional ingredients that actually work.

Biotech · Series A · Onsite · Based in New York

Transfyr

Building physical AI for science.

Biotech · Seed · Onsite · Based in Cambridge

Science

A brighter tomorrow enabled by neural engineering.

Biotech · Series C · Onsite · Based in Alameda

Astromech

Navigating the code of life.

Biotech · Seed · Remote · Based in San Francisco

Loyal

Extending the lifespan of dogs.

Biotech · Series C · Remote · Based in San Francisco

CuspAI

Frontier AI for breakthrough materials.

Biotech · Series B · Remote · Based in Cambridge

Colossal

The de-extinction company.

Biotech · Series C · Remote · Based in Dallas

Cradle

Engineer better proteins, faster.

Biotech · Series B · Remote · Based in Amsterdam